The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes
Authors:
- A. GallagherAGA. Gallagher
- P.D. HomePHP.D. Home
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 67 (3) , 196-203
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 27 references indexed in Scilit:
- Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Mealtime Treatment With Insulin Analog Improves Postprandial Hyperglycemia and Hypoglycemia in Patients With Non-Insulin-Dependent Diabetes MellitusArchives of internal medicine (1960), 1997
- Improved mealtime treatment of diabetes mellitus using an insulin analogueClinical Therapeutics, 1997
- Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic controlDiabetologia, 1995
- Do Insulin‐treated Diabetic Patients Use an Injection‐meal‐interval in Daily Life?Diabetic Medicine, 1995
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28AspDiabetic Medicine, 1993
- Hyperfibrinogenemia: An important risk factor for vascular complications in diabetesDiabetes Care, 1992
- Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experienceAmerican Heart Journal, 1990
- Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodiesDiabetologia, 1985